[In depth analysis of 2 studies of prostate cancer screening--what makes sense?].
Recker
F
F
Urologische Klinik, Kantonsspital Aarau, 5001 Aarau. franz.recker@ksa.ch
D015982:Bias; D014408:Biomarkers, Tumor / Q000097:blood*; D051517:Digital Rectal Examination; D005060:Europe; D006801:Humans; D008297:Male; D008403:Mass Screening; D011237:Predictive Value of Tests; D011446:Prospective Studies; D017430:Prostate-Specific Antigen / Q000097:blood*; D011471:Prostatic Neoplasms / Q000097:blood / Q000175:diagnosis* / Q000401:mortality; D016032:Randomized Controlled Trials as Topic; D015996:Survival Rate; D014481:United States
D014408:Biomarkers, Tumor; D017430:Prostate-Specific Antigen